Affinicon Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Affinicon General Information

Description

Developer of combination drugs designed to target dexamethasone to macrophages to combat inflammatory diseases. The company's combination drugs exploits a novel antibody-drug conjugate technology platform for targeted delivery of known drugs to macrophages where macrophages play a key role such as inflammation, infections and certain forms of cancer, enabling cancer patients to begin the treatment more quickly, resulting in a higher likelihood of a more successful treatment.

Contact Information

Website
www.affinicon.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Science Park Aarhus
  • Aabogade 15
  • 8200 Arhus
  • Denmark
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Science Park Aarhus
  • Aabogade 15
  • 8200 Arhus
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affinicon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Feb-2019 Completed Out of Business
2. Seed Round Completed Startup
1. Accelerator/Incubator 01-Oct-2013 Completed Startup
To view Affinicon’s complete valuation and funding history, request access »

Affinicon Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Affinicon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120276193-A1 Agents, uses and methods Inactive 29-Sep-2009

Affinicon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affinicon Acquisitions (1)

Affinicon’s most recent deal was a Merger/Acquisition with Cytoguide. The deal was made on 01-Oct-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cytoguide 01-Oct-2013 Merger/Acquisition Drug Discovery
To view Affinicon’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Affinicon FAQs

  • When was Affinicon founded?

    Affinicon was founded in 2013.

  • Where is Affinicon headquartered?

    Affinicon is headquartered in Arhus, Denmark.

  • What is the size of Affinicon?

    Affinicon has 3 total employees.

  • What industry is Affinicon in?

    Affinicon’s primary industry is Biotechnology.

  • Is Affinicon a private or public company?

    Affinicon is a Private company.

  • What is Affinicon’s current revenue?

    The current revenue for Affinicon is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »